Immune Biosolutions, Diex Research, Keyrus Life Science and the Faculty of Medicine and Health Sciences of the Université de Sherbrooke (FMSS) are joining forces to discover and develop innovative solutions against the SARS-CoV-2 virus.
Read More
Glycovax Pharma, a biopharmaceutical company based in Montréal, is actively working on the development of a new vaccine approach to counter COVID-19. The prototype glycoconjugate vaccine is currently in the preclinical phase.
Read More
New features, including fever, symptom and medication tracking, are now available for free to first-time users to support high-risk populations navigating COVID-19.
Read More
Roche Canada is pleased to announce the launch of the Roche Data Science Coalition, a group of like-minded public and private organizations committed to working with the global community to develop solutions to the challenges of the COVID-19 pandemic. The collaborators in the Coalition include: Alberta Machine Intelligence Institute (Amii), doc.ai, NVIDIA, Self Care Catalysts, ThinkData Works Inc and Vector Institute.
Read More
Laurent Pharmaceuticals Inc., a clinical-stage biopharmaceutical company that spun off from McGill University in 2012, today announces that it is planning to test its lead drug LAU-7b in patients with COVID-19 disease, as part of a Phase 2 clinical trial.
Read More
Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development has joined the battle to fight the novel COVID-19 virus. The Company will mobilize its expertise in regulatory affairs and quality assurance to support Canadian businesses seeking Health Canada approval for specific products used to mitigate the ongoing COVID-19 pandemic.
Read More
Nearly 120 individual companies took the time to respond to this survey - that's huge and very representative of our industry. This report contains important recommendations based on the responses we received.
Read More
Among the initiatives being suggested to find a solution to the COVID-19 pandemic is one originating from the Fonds de recherche du Québec and Génome Québec: they have mandated a group of researchers to create the Quebec COVID Biobank.
Read More
Here is a copy of the message sent by Anie Perrault, BIOQuébec’s Executive Director, to Minister Fitzgibbon's office on March 30. It was also sent to our colleagues at BIOTECanada, who are in contact with the federal government. More than ever, BIOQuébec has the interests of its members at heart!
Read More
The humanitarian costs of the coronavirus outbreak continue to mount, with more than 845,000 people infected globally. The number of people confirmed to have died having the virus has now surpassed 41,500.
Read More
JAMP Pharma Group, a Canadian pharmaceutical company, announced today that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus.
Read More
IMV Inc. announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s heritage across its DPX platform technology.
Read More
Canada is a global leader in artificial intelligence (AI)—the single-largest transformative technology in the world. Fostering Canada’s advantage in digital technologies, including AI, is one of the pillars of the Government of Canada’s economic growth strategy.
Read More
BIOQuébec welcomes the Quebec government’s newly tabled, balanced budget for 2020-2021, which acknowledges the biotechnology and life sciences sector’s economic role.
Read More
Immune Biosolutions, an early-stage biopharmaceutical company focusing on the discovery, engineering and development of therapeutic humanized chicken antibodies, today announced the appointments of Drs. Nadine Beauger and Louise Proulx to its Board of Directors.
Read More
ExCellThera Inc., an advanced biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that data from a Phase I/II clinical trial using its lead technology, ECT-001, will be presented at the 61st Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida.
Read More
Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval for a CAD 2.7M loan from the Quebec Government through its BioMed Propulsion program. This financing will help support the Company’s Phase 2 clinical study evaluating LAU-7b in adult patients with cystic fibrosis (“CF”).
Read More
The biotechnology and CRO industry issues 17 financing and public policy.
Read More
Today, Antech Diagnostics, part of Mars Petcare, announced its acquisition of Saint Hyacinthe, Quebec-based Biovet, a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally.
Read More
A government ally in the project aiming to attract $4 billion in private investments to Quebec by 2022 and make the province one of the five North American life sciences hubs, BIOQuébec is releasing the results of a major study on financing and public and regulatory policies which clearly describes the situation and identifies avenues to help us achieve our shared goals.
Read More